Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2013, Article ID 263846, 11 pages
http://dx.doi.org/10.1155/2013/263846
Research Article

Treatment with CB2 Agonist JWH-133 Reduces Histological Features Associated with Erectile Dysfunction in Hypercholesterolemic Mice

1Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne, Station 17, BM 5115, CH-1015 Lausanne, Switzerland
2Division of Cardiology, Geneva University Hospitals, Faculty of Medicine, Foundation for Medical Researches, 64, Avenue de la Roseraie, 1211 Geneva, Switzerland
3First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, 6 viale Benedetto XV, 16132 Genoa, Italy
4Department of Physiology and Biophysics, Biological Science Institute, Federal University of Minas Gerais, Avenida Antonio Carlos, 6627, 31270-901 Belo Horizonte, MG, Brazil

Received 23 July 2013; Revised 8 September 2013; Accepted 9 September 2013

Academic Editor: Federico Carbone

Copyright © 2013 Rodrigo Araujo Fraga-Silva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Rodrigo Araujo Fraga-Silva, Fabiana Pereira Costa-Fraga, Fabrizio Montecucco, et al., “Treatment with CB2 Agonist JWH-133 Reduces Histological Features Associated with Erectile Dysfunction in Hypercholesterolemic Mice,” Clinical and Developmental Immunology, vol. 2013, Article ID 263846, 11 pages, 2013. https://doi.org/10.1155/2013/263846.